Results 51 to 60 of about 7,444 (195)

Fulminant Giant Cell Myocarditis and Cardiogenic Shock: An Unusual Presentation of Malignant Thymoma

open access: yesCardiology Research and Practice, 2010
Malignant thymoma is rarely associated with giant cell myocarditis. We present a case study that illustrates this association and cardiogenic shock with underlying tamponade. The dramatic presentation of this scenario has not been previously described.
Deepak Koul   +7 more
doaj   +1 more source

Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab

open access: yesOncoImmunology, 2017
Autoimmune myocarditis is a rare but often fatal toxicity of checkpoint inhibitor immunotherapy. To improve the understanding of this complication, we performed immune profiling on post-mortem tissue from a patient with metastatic melanoma who had ...
Alexandre Reuben   +15 more
doaj   +1 more source

Oncologic Emergencies: Immune-Based Cancer Therapies and Complications [PDF]

open access: yes, 2020
Cancer therapies have undergone several recent advancements. Current cancer treatments include immune-based therapies comprised of checkpoint inhibitors, and adoptive immunotherapy; each treatment has the potential for complications that differ from ...
Brém, Elizabeth   +2 more
core  

Fatal idiopathic giant cell myocarditis in a young male: a diagnostic and therapeutic dilemma in a resource-limited setting

open access: yesAsian Journal of Internal Medicine
Idiopathic giant cell myocarditis (IGCM) is a rare and rapidly progressive form of myocarditis characterised by severe myocardial inflammation, rapid deterioration and high mortality without timely intervention.
N. M. M. Risly   +5 more
doaj   +1 more source

Mononuclear cell secretome protects from experimental autoimmune myocarditis [PDF]

open access: yes, 2017
Aims Supernatants of serum-free cultured mononuclear cells (MNC) contain a mix of immunomodulating factors (secretome), which have been shown to attenuate detrimental inflammatory responses following myocardial ischaemia.
Ankersmit, Hendrik Jan   +14 more
core  

Temporary mechanical circulatory support as a bridge to durable left ventricular assist device as destination therapy in fulminant giant cell myocarditis:A case report

open access: yesHeliyon
Fulminant giant cell myocarditis is a fatal form of acute myocarditis leading to a rapid-onset clinical presentation with lethal arrhythmias, acute heart failure, or cardiogenic shock requiring mechanical circulatory support.
Zhi-Ping Zhang   +3 more
doaj   +1 more source

GIANT CELL MYOCARDITIS IN HIV INFECTION: A FATAL TANDEM

open access: yesРоссийский кардиологический журнал, 2018
Giant cell myocarditis (GCM) is a rare autoimmune disease with the leading role of T-cell disorder in its pathogenesis. The associations are known of this disease with various autoimmunities, tumors, drug hypersensitivity.
S. Yu. Nikulina   +5 more
doaj   +1 more source

Is there an isolated arrhythmogenic right atrial myocarditis? [PDF]

open access: yes, 2017
Two cases with drug refractory ectopic atrial tachycardia are described. A map-guided partial resection of the right atrium (RA) was done after preoperative endocardial catheter mapping hadshown well-defined areas of fractionated RA potentials ...
FROMER, M.   +4 more
core  

Overexpression of Fgl2 deteriorates the heart function of experimenta l autoimmune myocarditis rats

open access: yesEuropean Journal of Inflammation, 2015
Studies have demonstrated that fibrinogen-like protein 2 (Fgl2) has been involved in immune and inflammatory responses which might contribute to the pathogenesis of immune-mediated diseases. Experimental autoimmune myocarditis (EAM) provided a model that
Z Zheng, H Huang, Y Yu, J Liang
doaj   +1 more source

Home - About - Disclaimer - Privacy